Survey from patients and institutions with experience of cancer genomic profiling tests.

Real-world survey from cancer patients and their institutions about experience of cancer genomic profiling tests. - Real-world survey about cancer genomic profiling tests.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030210547

Enrollment

4400

Registered

2022-01-13

Start date

2021-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant solid tumors Survey, Cancer genomic profiling tests

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cancer patients with experience of cancer genomic profiling tests under health insurance or Advanced Medical Care, Category B in Japan. Patients who agree to answer the survey. Parental or other representative agreement is acceptable when the informed consent from the patient is difficult such as in pediatric cancer patients.

Exclusion criteria

Exclusion criteria: Patients who was tested in hospitals that do not participate in this survey. Patients who decliene to answer this survey. Absence of parental or other representative agreement in pediatric cancer patients.

Design outcomes

Primary

Measure	Time frame
The details of patients who experience cancer genomic profiling tests The ratio of patients who can receive genome-matched therapies Levels of comprehension and satisfaction of the patients	—

Contacts

Public ContactKatsutoshi Oda

The University of Tokyo Hospital

panel-survey@adm.h.u-tokyo.ac.jp+81-3-3815-5411

Outcome results